A detailed history of Diversified Trust CO transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Diversified Trust CO holds 45,790 shares of CYDY stock, worth $6,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,790
Previous 45,790 -0.0%
Holding current value
$6,410
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

BUY
$2.12 - $7.15 $10,600 - $35,750
5,000 Added 12.26%
45,790 $124,000
Q4 2020

Jan 08, 2021

BUY
$2.02 - $6.0 $13,938 - $41,400
6,900 Added 20.36%
40,790 $220,000
Q3 2020

Oct 15, 2020

BUY
$2.92 - $6.48 $98,958 - $219,607
33,890 New
33,890 $99,000
Q2 2020

Jul 07, 2020

SELL
$2.25 - $8.77 $507,375 - $1.98 Million
-225,500 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$0.6 - $0.72 $135,300 - $162,360
225,500
225,500 $136,000

Others Institutions Holding CYDY

About CytoDyn Inc.


  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $114M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.